{"id":8542,"date":"2026-05-20T05:00:00","date_gmt":"2026-05-20T03:00:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=bffe59424bf2d39a3eb46c6740a92324"},"modified":"2026-05-20T05:00:00","modified_gmt":"2026-05-20T03:00:00","slug":"opch-investor-alert-kirby-mcinerney-llp-investigates-potential-claims-involving-option-care-health-inc","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=8542","title":{"rendered":"OPCH INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Option Care Health, Inc."},"content":{"rendered":"

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP<\/a> continues its investigation on behalf of Option Care Health, Inc. (\u201cOption Care Health\u201d or the \u201cCompany\u201d) (NASDAQ:OPCH) investors concerning the Company\u2019s and\/or members of its senior management\u2019s possible violation of the federal securities laws and other unlawful business practices.<\/p><\/a><\/a>

\n[LEARN MORE ABOUT THE INVESTIGATION<\/a>]<\/p>

\nWhat Happened?<\/b><\/p>

\nOn February 24, 2026, Option Care Health announced fourth quarter 2025 earnings. On the earnings call, the Company\u2019s guidance included a disclosed Stelara biosimilar gross-profit headwind of $25 million to $35 million for FY 2026. The Company also gave full year 2026 revenue guidance of $5.8B-$6.0B. CEO John Rademacher stated: \u201cWe are confident in the guidance we are putting forth and look forward to continuing our track record of execution.\u201d<\/p>

\nOn April 30, 2026, Option Care Health released its first quarter 2026 financial results, including revenue of only $1.35 billion (a 1.3% increase year over year) missing consensus estimates, as well as net income of $45.3 million, down 3.0% year over year, and an adjusted EBITDA of $104.8 million, down 6.3% year over year. The Company also lowered its full year 2026 guidance for revenue from $5.8B-$6.0B to $5.675B - $5.775B. The Company blamed its reduced guidance on \u201clower CID patient retention and therapy mix.\u201d On this news, the price of Option Care Health shares declined by $6.54 per share, or approximately 24%, from $26.87 per share on April 29, 2026 to close at $20.33 on April 30, 2026.<\/p>

\nWhat Should I Do?<\/b><\/p>

\nAt this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.<\/p>

\nIf you purchased or otherwise acquired Option Care Health securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro<\/a> of Kirby McInerney LLP<\/a> by email at investigations@kmllp.com<\/a>, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.<\/p>

\n[LEARN MORE ABOUT SECURITIES CLASS ACTIONS]<\/a><\/p>

\nKirby McInerney LLP<\/a> is a New York-based plaintiffs\u2019 law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm\u2019s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP\u2019s website<\/a>.<\/p>

\nThis press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.<\/p> Contacts<\/b>

\nKirby McInerney LLP\nLauren Molinaro, Esq.\n212-699-1171\nhttps:\/\/www.kmllp.com<\/a>https:\/\/securitiesleadplaintiff.com\/<\/a>investigations@kmllp.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–The law firm of Kirby McInerney LLP continues its investigation on behalf of Option Care Health, Inc. (\u201cOption Care Health\u201d or the \u201cCompany\u201d) (NASDAQ:OPCH) investors concerning the Company\u2019s and\/or members of its senior manag…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8542","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/8542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8542"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/8542\/revisions"}],"predecessor-version":[{"id":8543,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/8542\/revisions\/8543"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}